Thanks for posting that analysis. Seeking alpha often has some interesting analyses.

More broadly, vaccines will not be wholly effective, will take a long time to deploy and will not be taken universally.

The need for leronlimab will (unfortunately) exceed supply in Covid alone. We will shortly (in a medical/investing but not day trading timeline) see leronlimab administered for many of the indications on ohm20 master list.

I’m all for vaccines, but have no direct investment in vaccine companies.